DEBRA ODINK Insider Trading $ANTH Anthera Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEBRA ODINK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEBRA ODINK. DEBRA ODINK is Chief Technology Officer in Anthera Pharmaceuticals Inc ($ANTH).
DEBRA ODINK in Anthera Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEBRA ODINK: Chief Technology Officer
Holdings: 13,855 shares
Current Value: $8,174
Latest Transaction: Jan 02 2015
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DEBRA ODINK in Anthera Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 1.61 | 120,000 | 193,200 | 120,000 | |
| Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 1,364 | 0 | 13,855 | 12.5 K to 13.9 K (+10.92 %) |
| Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 1,364 | 0 | 9,101 | 10.5 K to 9.1 K (-13.03 %) |
| Mar 27 2014 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 3.30 | 10,070 | 33,231 | 10,070 | |
| Mar 27 2014 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Grant | A | 0.00 | 3,864 | 0 | 10,465 | 14.3 K to 10.5 K (-26.97 %) |
| Mar 27 2014 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Payment of Exercise | F | 3.30 | 2,783 | 9,184 | 6,601 | 9.4 K to 6.6 K (-29.66 %) |
| Jul 02 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Payment of Exercise | F | 0.49 | 2,248 | 1,102 | 75,074 | 77.3 K to 75.1 K (-2.91 %) |
| May 21 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 0.61 | 1,400,000 | 854,000 | 1,400,000 | |
| Mar 27 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Grant | A | 0.00 | 49,519 | 0 | 77,322 | 27.8 K to 77.3 K (+178.11 %) |
| Jan 11 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 4,009 | 0 | 99,937 | 95.9 K to 99.9 K (+4.18 %) |
| Jan 11 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 4,009 | 0 | 27,803 | 31.8 K to 27.8 K (-12.60 %) |
Page: 1